![Terence Winters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Terence Winters
Private Equity Investor at
Valley Ventures
Profile
Dr. Terence E.
Winters is Special Limited Partner at Valley Ventures.
He joined the firm in 1993.
He has over 25 years experience in venture investing and has been a member of many public and private pharmaceutical, device and diagnostic company boards, including CollaGenex Pharmaceuticals, OrthoLogic, Creative BioMolecules, Microgenics, Clinuvel Pharmaceuticals and Ascent Healthcare.
Dr. Winters came to the United States for a post doctoral fellowship at UCLA, then joined first Goodyear and subsequently Diamond Shamrock in research and technology transfer positions.
He entered the venture capital business in 1981 as VP of DS Ventures, Diamond Shamrock’s venture investing arm, then was a founding partner of Columbine Venture Funds, with two funds of over $80M in capital.
Dr. Winters holds a BSc and PhD in chemistry at the University of Wales.
Terence Winters active positions
| Companies | Position | Start |
|---|---|---|
Valley Ventures
 Valley Ventures Investment ManagersFinance Valley Ventures invests in companies located in the southwestern United States. The firm targets companies operating in the fields of proprietary life science, pharmaceuticals, device and diagnostics services. It provides financing for early and later stage capital requirements. | Private Equity Investor | 1992-12-31 |
Former positions of Terence Winters
| Companies | Position | End |
|---|---|---|
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Chief Executive Officer | 2017-12-30 |
| CLINUVEL PHARMACEUTICALS LIMITED | Director/Board Member | 2007-05-31 |
| CAPSTONE HOLDING CORP. | Director/Board Member | - |
Diamond Shamrock, Inc.
 Diamond Shamrock, Inc. Oil Refining/MarketingEnergy Minerals Crude oil refining & natural gas processi | Corporate Officer/Principal | - |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medical therapies to the dental & dermatology market | Director/Board Member | - |
Training of Terence Winters
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
25
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Diamond Shamrock, Inc.
Diamond Shamrock, Inc. Oil Refining/MarketingEnergy Minerals Crude oil refining & natural gas processi | Energy Minerals |
Capstone Holding Corp.
 Capstone Holding Corp. Wholesale DistributorsDistribution Services Operates as a holding company whose subsidiary distributes masonry stone products for residential and commercial construction industry | Distribution Services |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medical therapies to the dental & dermatology market | Health Technology |
AmpliMed Corp.
 AmpliMed Corp. Pharmaceuticals: MajorHealth Technology Provides biotechnological services | Health Technology |
Clinuvel Pharmaceuticals Ltd.
 Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
University of Wales (Bangor)
 University of Wales (Bangor) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valley Ventures
Valley Ventures Investment ManagersFinance Valley Ventures invests in companies located in the southwestern United States. The firm targets companies operating in the fields of proprietary life science, pharmaceuticals, device and diagnostics services. It provides financing for early and later stage capital requirements. | Finance |
- Stock Market
- Insiders
- Terence Winters
